-
Andrew Mark
Pardoll is
Director of the Bloomberg-Kimmel
Institute for
Cancer Immunotherapy and
Abeloff Professor of Oncology, Medicine,
Pathology and...
-
Yamazaki T,
Akiba H, Iwai H,
Matsuda H, Aoki M,
Tanno Y, Shin T,
Tsuchiya H,
Pardoll DM,
Okumura K,
Azuma M,
Yagita H (November 2002). "Expression of programmed...
- Immunity. 3 (5): 541–7. doi:10.1016/1074-7613(95)90125-6. PMID 7584144.
Pardoll DM (December 2012). "Immunology
beats cancer: a
blueprint for successful...
- Domb
Cytokine Enhanced Immunotherapy for
Brain Tumors Henry Brem, Drew M.
Pardoll, Reid C. Thompson,
Elizabeth M. Jaffee, Kam W. Leong,
Matthew G. Ewend...
-
Retrieved 12 June 2012.
Sotomayor MG, Yu H,
Antonia S,
Sotomayor EM,
Pardoll DM (2002). "Advances in gene
therapy for
malignant melanoma".
Cancer Control...
- PMID 18376402. S2CID 19811684. Huang, AY; Golumbek, P; Ahmadzadeh, M; Jaffee, E;
Pardoll, D; Levitsky, H (1994). "Role of bone marrow-derived
cells in presenting...
-
transfer Cancer immunotherapy Chimeric antigen receptor Immune checkpoint Pardoll DM (March 2012). "The
blockade of
immune checkpoints in
cancer immunotherapy"...
- PMC 5924692. PMID 29311378. Topalian,
Suzanne L.; Drake,
Charles G.;
Pardoll, Drew M. (April 2015). "Immune
Checkpoint Blockade: A
Common Denominator...
-
Nature medicine, 1(12), p.1297.doi:10.1038/nm1295-1297 Fearon, E.R.,
Pardoll, D.M., Itaya, T., Golumbek, P., Levitsky, H.I., Simons, J.W., Karasuyama...
-
Tangsombatvisit S,
Grosso JF,
Netto G,
Smeltzer MP,
Chaux A, Utz PJ,
Workman CJ,
Pardoll DM,
Korman AJ,
Drake CG,
Vignali DA (February 2012). "Immune inhibitory...
